RxDoctor Payments DataLook up a doctor →

Alan Wiseman, MD

Cardiovascular Disease · Bangor, MENPI 1629049200

Payments from drug & device makers

$3,329,140in general payments, 2019–2025

Across 396 payments — averaging $8406.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1M
  • CSL Behring$1M
  • Amgen$781K
  • Regeneron$121K
  • AstraZeneca$112K
  • Janssen Research & Development, LLC$104K
  • plus $143K from 8 others

General payments by program year

20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,329,140 in reported general payments places this provider in the 95th percentile of 99 cardiovascular disease providers in Maine.

See all cardiovascular disease providers in Maine

Medicare billing

Part B allowed, 2024
$78,661
Medicare patients
1,113
Services billed
1,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Bangor

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →